期刊文献+

1999~2008年国内文献报道的预防接种引起过敏性休克病例分析 被引量:2

Case Analysis of Anaphylactic Shock Following Vaccination Reported in Domestic Literature from 1999 to 2008
原文传递
导出
摘要 [目的]总结预防接种引起过敏性休克的临床特征、流行病学特点和应对措施。[方法]对1999~2008年国内文献报道的70例预防接种引起的过敏性休克病例进行分析。[结果]70例病人由17种疫苗引起,死亡5例。接种狂犬病疫苗、乙脑疫苗、乙肝疫苗引起的合计41例(占58.57%)。疫苗接种后〈30min发生的占78.57%,30-60min发生的占10.00%;〉60min发生的占11.43%;28例合并过敏性皮疹;5例有药物过敏史,2例有食物过敏史,1例有疫苗接种过敏史。[结论]单价多针次灭活疫苗是引起预防接种过敏性休克的主要疫苗品种。 [Objective]To sum up clinical features,epidemiological characteristics and countermeasures of anaphylactic shock following vaccination. [Methods]Data of 70 cases of anaphylactic shock following vaccination reported in domestic literature from 1999 to 2008 were analyzed. [Results]70 cases were caused by 17 different vaccines, 5 cases died. 41 of them were caused by rabies,Japanese encephalitis vaccine, and hepatitis B vaccine, accounting for 58.57 %. Anaphylaetic shock occurred following vaccination within 30 minutes accounted for 78. 57 %, 30-60 minutes accounted for 10.00 %, over 60 minutes accounted for 11. 430%. 28 cases had the complication with allergic skin rash, 5,2 cases and 1 case had the history of drug allergy,food allergy and the allergy of vaccination. [Conclusion]Singe valent inactivated vaccines with more doses were the main vaccines causing anaphylactic shock following vaccination.
出处 《预防医学论坛》 2009年第10期1013-1014,共2页 Preventive Medicine Tribune
关键词 疫苗 预防接种 过敏性休克 Vaccine Vaccination Anaphylactic Shock
  • 相关文献

参考文献2

二级参考文献1

共引文献95

同被引文献22

  • 1沈江建.流行性乙型脑炎减毒活疫苗与灭活疫苗免疫效果及人体接种反应观察[J].现代医药卫生,2005,21(22):3184-3185. 被引量:2
  • 2卫生部.2009年秋冬季甲型H1N1流感疫苗预防接种指导意见[s].2009-09-10.
  • 3Helbling A, Hurni T, Mueller UR, et al. Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940 000 inhabitants of the Swiss Canton Bern [J]. Clinical & Experimental Allergy, 2004, 34 (2) :285-290.
  • 4卫生部.预防按种工作规范[S].2005-09-20.
  • 5Liang XF, Wang HQ, Wang JZ, et al. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a muhicentre, double-blind, randomised, placebo-controlled trial [J ]. The Lancet, 2009, 375 (9708) : 56-66.
  • 6Zhu FC, Wang H, Fang HH, et al. A Novel Influenza A (H1N1) Vaccine in Various Age Groups [ J 1. N Engl J Med, 2009, 361 (25) : 2414-2423.
  • 7Clark TW, Pareek M, Hoschler K, et al. Trial of Influenza A (H1N1) 2009 Monovalent MF59-Adjuvanted Vaccine-Preliminary Report [J]. N Engl J Med, 2009, 361 (25): 2424-2435.
  • 8曲正海,高美华.儿童变态反应病学[M].北京:人民卫生出版社,2006:529-533.
  • 9J U Ruggeberg, MS Gold, JM Bayas. Anaphylaxis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data[J] .Vaccine, 2007, 25 (31) : 5675-5684.
  • 10WHO. Immunization safety surveillance: guidelines for managers of immunization programmes on reporting and investigating adverse events following immunization [S]. WPRO/EPI/99.01.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部